Gene | Associated with SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO in | Link to HGNC | Cytogenetic band | Number of associated diseases | Associated diseases |
---|---|---|---|---|---|
HLA-B | OMIM | HGNC link | 6p21.33 | 2 | 608579, PS106300 |
HLA-A | OMIM | HGNC link | 6p22.1 | 1 | 608579 |
Download the disease annotation in CSV format
Common tandem group | Number of genes in this tandem group associated to this disease | Genes in this tandem group associated to this disease |
---|---|---|
Group 281 | 2 | HLA-A, HLA-B |
Shared region | Number of genes associated with the disease | Genes associated with the disease |
---|---|---|
6p2 | 2 | HLA-A, HLA-B |
regulated gene | associated to this disease | # TFs | TFs | # TFs associated with this disease | TFs associated with this disease |
---|---|---|---|---|---|
HLA-B | YES | 4 | CIITA, MYC, HIVEP2, MYCN | 0 | |
HLA-A | YES | 6 | IRF1, HIVEP2, RELA, CIITA, MYC, MYCN | 0 |
Gene1 | Gene2 | Direct Interaction | Number of shared interactors | Shared genes in interaction |
---|---|---|---|---|
HLA-B | HLA-A | Yes | 12 | TAP2, VCP, HLA-E, HLA-B, LILRB1, TAP1, B2M, ERBB3, CD8A, HLA-C, ENV, MMS19 |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
Gene1 | Gene2 | Interaction | Number of common interactors | Common genes in interaction |
---|---|---|---|---|
HLA-B | HLA-A | No | 2 | B2M, TRAC |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
Gene1 | Gene2 | Direct interaction | More information |
---|---|---|---|
HLA-A | HLA-B | yes, complex | They form a heterodimer of an alpha chain and a beta chain. [UniProt] |
KEGG term | KEGG term ID | IC | Number of genes with the same term | Genes |
---|---|---|---|---|
Antigen processing and presentation | hsa04612 | 6.04 | 2 | HLA-B, HLA-A |
Herpes simplex infection | hsa05168 | 5.08 | 2 | HLA-B, HLA-A |
Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 | 2 | HLA-B, HLA-A |
Autoimmune thyroid disease | hsa05320 | 6.62 | 2 | HLA-B, HLA-A |
Allograft rejection | hsa05330 | 6.91 | 2 | HLA-B, HLA-A |
Viral carcinogenesis | hsa05203 | 5.08 | 2 | HLA-B, HLA-A |
Graft-versus-host disease | hsa05332 | 6.84 | 2 | HLA-B, HLA-A |
Cell adhesion molecules (CAMs) | hsa04514 | 5.36 | 2 | HLA-B, HLA-A |
Phagosome | hsa04145 | 5.27 | 2 | HLA-B, HLA-A |
Endocytosis | hsa04144 | 4.92 | 2 | HLA-B, HLA-A |
Type I diabetes mellitus | hsa04940 | 6.79 | 2 | HLA-B, HLA-A |
HTLV-I infection | hsa05166 | 4.59 | 2 | HLA-B, HLA-A |
Viral myocarditis | hsa05416 | 6.45 | 2 | HLA-B, HLA-A |
Epstein-Barr virus infection | hsa05169 | 4.97 | 2 | HLA-B, HLA-A |
REACTOME term | REACTOME term ID | IC | Number of genes with the same term | Genes |
---|---|---|---|---|
Antigen processing-Cross presentation | R-HSA-1236975 | 5.88 | 2 | HLA-B, HLA-A |
Immune System | R-HSA-168256 | 2.37 | 2 | HLA-B, HLA-A |
ER-Phagosome pathway | R-HSA-1236974 | 6.08 | 2 | HLA-B, HLA-A |
Endosomal/Vacuolar pathway | R-HSA-1236977 | 6.92 | 2 | HLA-B, HLA-A |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 | 2 | HLA-B, HLA-A |
Interferon Signaling | R-HSA-913531 | 4.95 | 2 | HLA-B, HLA-A |
Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.65 | 2 | HLA-B, HLA-A |
Interferon gamma signaling | R-HSA-877300 | 5.67 | 2 | HLA-B, HLA-A |
Interferon alpha/beta signaling | R-HSA-909733 | 6.04 | 2 | HLA-B, HLA-A |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.64 | 2 | HLA-B, HLA-A |
Adaptive Immune System | R-HSA-1280218 | 3.19 | 2 | HLA-B, HLA-A |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.7 | 2 | HLA-B, HLA-A |
GO | IC | Number of genes with the same GO | Genes |
---|---|---|---|
peptide binding (GO:0042277) | 4.22 | 2 | HLA-B, HLA-A |
antigen binding (GO:0003823) | 5.02 | 2 | HLA-B, HLA-A |
peptide antigen binding (GO:0042605) | 6.18 | 2 | HLA-B, HLA-A |
amide binding (GO:0033218) | 4.14 | 2 | HLA-B, HLA-A |
binding (GO:0005488) | 0.18 | 2 | HLA-B, HLA-A |
protein binding (GO:0005515) | 0.46 | 2 | HLA-B, HLA-A |
TAP binding (GO:0046977) | 7.79 | 2 | HLA-B, HLA-A |
receptor binding (GO:0005102) | 2.43 | 2 | HLA-B, HLA-A |
Term | New enriched term | IC | P value | Genes |
---|---|---|---|---|
peptide antigen binding (GO:0042605) | - | 6.18 | 0.0 | HLA-B, HLA-A |
amide binding (GO:0033218) | - | 4.14 | 0.0 | HLA-B, HLA-A |
binding (GO:0005488) | - | 0.18 | 0.0 | HLA-B, HLA-A |
antigen binding (GO:0003823) | - | 5.02 | 0.0 | HLA-B, HLA-A |
TAP binding (GO:0046977) | - | 7.79 | 0.0 | HLA-B, HLA-A |
peptide binding (GO:0042277) | - | 4.22 | 0.0 | HLA-B, HLA-A |